QNRX
Quoin Pharmaceuticals, Ltd.
Next earnings Aug 5, 2026 · consensus $-1.64 EPS
Last earnings -0.9% on 2026-05-07
$4.20
▲ +9.66%$4.20▼ -51.72%
over 1Y
L $3.25EODHDH $22.30
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+9.7%
1W-9.7%
1M-13.2%
3M-44.5%
YTD-70.2%
1Y-51.7%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 9 analysts
Buy
Conservative balance sheet (liabilities/equity 0.55x).
Quoin Pharmaceuticals, Ltd. shows $0.00 in FY2021 revenue, and -120.5% ROE.
Sources: SEC EDGAR (CIK 0001671502, latest 10-Q filed 2026-05-07) · EODHD · as of 6/22/2026, 10:55:12 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.